Results 191 to 200 of about 53,816 (275)

Predicting Stereotactic Body Radiation Therapy Response Using an AI-Based Tumor Vessel Biomarker. [PDF]

Technol Cancer Res Treat
Park JH, Lim JH, Kim S, Kim CH, You S, Choi JS, Chang JW, Park D, Lee MW, Kim S, Jo IY, Byeon HK, Park KN, Lee BJ, Shin SC, Cheon YI, Heo J.   +16 more
europepmc   +1 more source

CTSC Confers Radioresistance in Hepatocellular Carcinoma by Regulating Myeloid‐Derived Suppressor Cells

Journal of Cellular and Molecular Medicine, Volume 30, Issue 8, April 2026.
ABSTRACT Radiotherapy is an important therapeutic modality for advanced hepatocellular carcinoma (HCC), but the limited understanding of radioresistance mechanisms in HCC has hindered its further clinical development. This work aimed to clarify the essential role of Cathepsin C (CTSC) in regulating radioresistance in HCC.
Jiahuan Xu, Bilin Zhang, Shirui Yang, Shaoran Song, Jie Wu, Yunzhi Dang   +5 more
wiley   +1 more source

Dosimetric Challenges of Small Lung Lesions in Low-Density Tissue Treated with Stereotactic Body Radiation Therapy. [PDF]

J Clin Med
Das IJ, Ding M, Abazeed ME.
europepmc   +1 more source

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma [PDF]

, 2017
Ryan S. Youland, Annie T. Packard, M.J. Blanchard, Andrea Arnett, Gregory A. Wiseman, Lisa A. Kottschade, Roxana Dronca, Svetomir N. Markovic, Kenneth R. Olivier, Sean S. Park   +9 more
openalex   +1 more source

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Eric Baudin, Alice Durand, Wieneke Buikhuisen, Jaume Capdevila, Martyn Caplin, Christophe M. Deroose, Clarisse Dromain, Antongiulio Faggiano, Pier Luigi Filosso, Gregory Kaltsas, Marco Volante, Thomas Walter, Rocio Garcia‐Carbonero   +12 more
wiley   +1 more source

Functional lung avoidance stereotactic body radiation therapy for central lung cancer patients. [PDF]

Quant Imaging Med Surg
Feng A, Duan Y, Shao Y, Wang H, Chen H, Gu H, Huang Y, Shen Z, Wang X, Xu Z.   +9 more
europepmc   +1 more source

Predictors of multidomain decline in health‐related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer [PDF]

, 2016
Robert T. Dess, Will Jackson, Simeng Suy, Payal Soni, Jae Lee, Ahmed Abugharib, Zachary S. Zumsteg, Felix Y. Feng, Daniel A. Hamstra, Sean P. Collins, Daniel E. Spratt   +10 more
openalex   +1 more source

Radiological Loco‐Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is being diagnosed with increasing frequency worldwide. We performed a systematic review on radiofrequency (RFA), microwave (MWA), irreversible electroporation (IRE), trans‐arterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) in CCA. Thirty‐
Dimitrios Pallas, Claudia Campani, Olivier Sutter, Pierre Nahon, Nathalie Ganne‐Carrié, Olivier Seror, Jean‐Charles Nault   +6 more
wiley   +1 more source

Stereotactic body radiation therapy in patients with unresectable hepatocellular carcinoma and portal vein tumor thrombosis. [PDF]

World J Hepatol
Khosla D, Gade VKV, Kapoor R, Singh G, Singh R, Taneja S, Premkumar M, Kalra N, De A, Bhujade H, Verma N, Duseja A, Gupta R.   +12 more
europepmc   +1 more source

Multimodal Nuclear Imaging Response as a Prognostic Indicator Following Spine Stereotactic Body Radiation Therapy. [PDF]

Adv Radiat Oncol
Dibs K, Tocaj G, Palmer J, Raval R, Beyer S, Zhu S, Singh R, Gogineni E, Kumar P, Lonser R, Thomas E, Grecula J, Chakravarti A, Xu D, Elder J, Bourekas E, Blakaj DM.   +16 more
europepmc   +1 more source